BeOne Medicines (ONC) Other Non-Current Assets (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Non-Current Assets data on file, last reported at $104.2 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 30.45% year-over-year to $104.2 million in Q1 2026; TTM through Mar 2026 was $104.2 million, a 30.45% decrease from a year earlier, with the FY2025 full-year figure at $102.4 million, down 36.18% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $104.2 million, up from $102.4 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for ONC reached as high as $201.2 million in Q3 2024 and fell as low as $3.9 million in Q2 2022.
• Historically, Other Non-Current Assets has averaged $121.2 million across 5 years, with a median of $140.6 million in 2022.
• Across the five-year window, Other Non-Current Assets slumped 60.32% in 2022 and jumped 3910.09% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $75.1 million in 2022, then soared by 66.89% to $125.4 million in 2023, then increased by 28.02% to $160.5 million in 2024, then sank by 36.18% to $102.4 million in 2025, then gained by 1.78% to $104.2 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $104.2 million in Q1 2026, $102.4 million in Q4 2025, and $136.2 million in Q3 2025.